"YAG Laser Vitreolysis vs Sham YAG Vitreolysis for Symptomatic Vitreous Floaters httpjamanetwork.comjournalsjamaophthalmologyfullarticle.jamaophthalmol..  JAMA Ophthalmology Invited Commentary YAG Laser VitreolysisIs It as Clear as It Seems httpjamanetwork.comjournalsjamaophthalmologyfullarticle.jamaophthalmol..  EMBARGOED FOR RELEASE  A.M. ET THURSDAY JULY   Media Advisory To contact corresponding author Chirag P. Shah M.D. M.P.H. email cpshaheyeboston.com mailtocpshaheyeboston.com. Related material The commentary YAG Laser VitreolysisIs It as Clear as It Seems by Jennifer I. Lim M.D. of the University of Illinois at Chicago and Editor JAMA Ophthalmology also is available at the For The Media website httpmedia.jamanetwork.com. To place an electronic embedded link to this article in your story Link will be live at the embargo time httpjamanetwork.comjournalsjamaophthalmologyfullarticle.jamaophthalmol.. JAMA Ophthalmology Patients reported improvement in symptoms of eye floaters after treatment with a laser according to a study published by JAMA Ophthalmology. Floaters become more prevalent with age and although most patients grow accustomed to them many find them bothersome and they can worsen visual quality. Three management options exist for floaters patient education and observation surgery and the laser procedure YAG vitreolysis of which there are limited published studies on its effectiveness for treating floaters. Chirag P. Shah M.D. M.P.H. and Jeffrey S. Heier M.D. of the Ophthalmic Consultants of Boston randomly assigned  patients  eyes to receive YAG laser vitreolysis n   in one session or a sham placebo laser treatment control n  . Six months after treatment the YAG group reported significantly greater improvement in selfreported floaterrelated visual disturbance  percent compared with sham controls  percent. A total of  patients  percent in the YAG laser group reported significantly or completely improved symptoms vs  individuals in the sham group. Several measures of quality of life also improved compared with those in the sham laser group including general vision and independence. No differences in adverse events between groups were identified. A limitation of the study was its small sample size and short followup period. Greater confidence in these outcomes may result from larger confirmatory studies of longer duration the authors write. For more details and to read the full study please visit the For The Media website httpmedia.jamanetwork.com. doi.jamaophthalmol.."